Jennifer Wilkie is a partner in Gowling WLG's Ottawa office, and a member of the firm’s Patents, Intellectual Property Litigation & Strategy and Life Sciences Groups. Jennifer has over 20 years of experience in the IP field, including 16 years as a Registered Patent Agent. Jennifer’s accomplishments in IP have been recognized by Best Lawyers in Canada. Jennifer’s practice has focused primarily on patents, especially patent litigation and patent prosecution, with an emphasis on pharmaceutical and chemical patents. Jennifer regularly acts for clients in patent infringement and patent impeachment matters, as well as applications under the Patented Medicines (Notice of Compliance) Regulations. She has appeared in the Federal Court and Federal Court of Appeal, as well as the Ontario Courts. Her practice also involves providing strategic advice on patent portfolio management and enforcement. In the pharmaceutical context, this includes advice as to patent listing, innovative drug listing, life cycle management and regulatory requirements under the Food and Drugs Act and Regulations, and with respect to the PMPRB. Jennifer is a regular writer on IP issues. She is also executive editor of Gowling WLG's PharmaFlash newsletter.